Compare AU
Compare GGUS vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the S&P US 500 (geared) (GGUS) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
GGUS | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 233 | 63 |
Median incremental investment | $1,024.50 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,905.94 | $1,905.75 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
GGUS | DRUG | |
|---|---|---|
Strategy | GGUS.AX was created on 2015-08-17 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund provides investors with a simple way to obtain a cost-effective geared exposure to the returns of the U.S. sharemarket, hedged to Australian Dollars. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | ISHARES CORE S&P 500 ETF (216.81 %) AUD - AUSTRALIA DOLLAR (93.01 %) USD - UNITED STATES DOLLAR (-209.83 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (83.88 %) Communication Services (16.12 %) | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) |
Top 3 countries | United States (99.40 %) Switzerland (0.28 %) Netherlands (0.13 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.8 % | 0.57 % |
Key Summary
GGUS | DRUG | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | |
Asset class | ETF | ETF |
Management fee | 0.8 % | 0.57 % |
Price | $46.87 | $8.25 |
Size | $268.767 million | $182.401 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.85 % | 1.90 % |
Market | ASX | ASX |
First listed date | 18/08/2015 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
GGUS | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 233 | 63 |
Median incremental investment | $1,024.50 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,905.94 | $1,905.75 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
GGUS | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
GGUS | DRUG |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |